Digital Therapeutics for People Living with Moderate to Severe Depression
Dennis Urbaniak, Executive Vice President of Digital Therapeutics at Orexo, a pharmaceutical and digital therapeutics company that addresses the unmet n...
5304 articles
Dennis Urbaniak, Executive Vice President of Digital Therapeutics at Orexo, a pharmaceutical and digital therapeutics company that addresses the unmet n...
Irwin Stromeyer, Owner, Sterile Space Infection Defence, LLC, discusses biopreparedness, the current 'twin-demic’ of COVID and FLU or 'Flurona', and s...
Amy Peterson, MD, President and Chief Operating Officer at CytomX Therapeutics, Inc. Learn more on Health Professional Radio.
Vivek Shah, MD, Director of Outpatient Arthroplasty in the Department of Orthopedics and a member of the faculty at Harvard Medical Schoo...
Jennifer Lewey, M.D., MPH, and Go Red for Women volunteer talks about how nearly 45% of women in their twenties and up are living with some form of ca...
Prash Puspanathan, co-founders of Enosis Therapeutics, an Australia-based medical technology and psychedelic research company, formed to advance experie...
Jeff Stark, Head of US Medical Immunology at UCB, discusses new long-term complete skin clearance data for bimekizumab in the treatment of moderate to s...
Kathryn Lowe, MD, FAAP, a pediatrician discusses the new American Academy of Pediatrics' (AAP) first book "You-ology: A Puberty Guide for Every Body" (A...
Philip Tierno, Professor of Microbiology and Pathology at NYU School of Medicine discusses how air quality is now a priority in hospitals and rehabilita...
Trish Richardson, MSN, BSBA, RN, NE-BC, CMSRN, Director of Post-Acute Care Solutions at Relias, a healthcare training and performance solutions company,...